SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-001779
Filing Date
2024-01-22
Accepted
2024-01-22 06:01:09
Documents
13
Period of Report
2024-01-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20240121_8k.htm   iXBRL 8-K 24294
  Complete submission text file 0001437749-24-001779.txt   170462

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20240117.xsd EX-101.SCH 3852
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20240117_def.xml EX-101.DEF 13384
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20240117_lab.xml EX-101.LAB 17551
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20240117_pre.xml EX-101.PRE 13361
7 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20240121_8k_htm.xml XML 4278
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 24546975
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)